1. Market Research
  2. > Healthcare Market Trends
  3. > CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines

Summary

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Philippines. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Philippines. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

In 2015, Philippines population was approximately at 100.9 million. The government of Philippines has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country’s future growth. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market. The Philippines pharmaceutical market is the third-largest pharmaceutical market in the Association of Southeast Asian Nations (ASEAN), after Indonesia and Thailand. The Pharmaceutical market was estimated to be worth $3.4 billion in 2015 and expected to reach $4.1 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 3.7% over the 2008-2020 period. The medical device market was valued at $400m in 2008 and is expected to reach approximately $600m by 2020, at a projected CAGR of 8.1%.

These positive trends can primarily be attributed to -
- An increasing elderly population in Philippines, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices
- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Philippines, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (United Laboratories, Pfizer, GlaxoSmithKline, Novartis, Merck Co.)
- An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
- An overview of the opportunities for and challenges to growth in the Philippines healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving Philippines healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in Philippines healthcare market

Table Of Contents

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Philippines
1 Table of Contents
1 Table of Contents 6


2 Introduction 16
2.1 GlobalData Report Guidance 16
3 Overview of Pharmaceutical and Medical Device Market 17
3.1 Pharmaceutical Market 17
3.1.1 Market Overview 17
3.1.2 Pharmaceutical Exports and Imports 21
3.1.3 Supply Channels 22
3.1.4 Market Segments 23
3.1.5 Overview of Major Disease Areas 25
3.1.6 Major Players 28
3.2 Medical Device Market 67
3.2.1 Market Overview 67
3.3 Market Drivers and Barriers 67
3.3.1 Drivers 67
3.3.2 Barriers 68
4 Market Access 70
4.1 Reimbursement and Payer Landscape 70
4.1.1 Overview of Healthcare System 70
4.1.2 Reimbursement Process 71
4.1.3 Overview of Insurance Providers 75
4.1.4 Patient Share in Healthcare Spending 80
4.1.5 Price Trends in the Healthcare Sector 82
4.1.6 Pricing Policies 83
4.2 Regulatory Landscape 84
4.2.1 Overview of Regulatory Agencies 84
4.2.2 Market Authorization Procedure for Pharmaceutical Products 85
4.2.3 New Medical Device Approval Process 91
4.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing 91
4.2.5 Exports and Imports 92
4.2.6 Intellectual Property Rights 95
4.2.7 Clinical Trial Regulations 99
4.2.8 Pharmaceutical Advertising Regulations 102
4.2.9 Pharmacy Regulations 103
4.2.10 Labeling and Packaging Regulations 104
5 Country Analysis 106
5.1 Political Environment 106
5.1.1 Political Structure 106
5.1.2 Analysis of Current Political Environment 107
5.1.3 Healthcare Policy Initiatives 108
5.2 Economic Landscape 113
5.3 Economic Indicators 118
5.3.1 Gross Domestic Product 118
5.3.2 Gross National Income 122
5.3.3 Inflation 123
5.3.4 Currency Exchange Rate 125
5.3.5 Foreign Direct Investment 126
5.3.6 Foreign Exchange Reserves 127
5.3.7 Trade Balance 128
5.3.8 Fiscal Deficit 130
5.3.9 General Government Gross Debt 131
5.3.10 External Debt 132
5.3.11 Major Industries 133
5.4 Demographics 136
5.4.1 Population 136
5.4.2 Education and Literacy 153
5.4.3 Employment 155
5.4.4 Disease Burden 156
5.5 Healthcare Infrastructure 159
5.5.1 Healthcare Facilities 159
5.5.2 Healthcare Parameters 164
5.5.3 Environmental Health 165
5.5.4 Healthcare Personnel 167
5.6 Healthcare Expenditure 170
5.6.1 Overview 170
5.6.2 Major Components of Healthcare Spending 171
5.6.3 Share of Public and Private Sector 172
5.6.4 Spending in Pharmaceutical RandD 173
5.7 Trade Associations 173
5.7.1 Pharmaceutical and Healthcare Association of the Philippines 173
5.7.2 The Philippine Pharmaceutical Manufacturers Association 173
5.7.3 The Philippine Pharmacist Association 173
5.7.4 The Philippine Medical Association 174
5.8 Trade Fairs 174
6 Opportunities and Challenges 175
6.1 Opportunities 175
6.2 Challenges 175
7 Appendix 178
7.1 Abbreviations 178
7.2 Bibliography 181
7.3 Research Methodology 196
7.3.1 Coverage 196
7.3.2 Secondary Research 196
7.3.3 Forecasts 197
7.3.4 Expert Panel 197
7.4 Disclaimer 198

1.1 List of Tables
Table 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015 20
Table 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020 20
Table 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014 21
Table 4: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 23
Table 5: Pfizer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015 34
Table 6: Pharmaceutical Market, Pfizer, Late-Stage Pipeline, 2016 35
Table 7: GlaxoSmithKline, Global, Major Products Revenue ($m) and Annual Growth (%), 2015 42
Table 8: Pharmaceutical Market, GlaxoSmithKline, Late-Stage Pipeline, 2016 43
Table 9: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015 50
Table 10: Pharmaceutical Market, Novartis, Planned Filings, 2014-2018 51
Table 11: Merck and Co., Global, Major Products, Revenue ($bn) and Annual Growth (%), 2015 59
Table 12: Pharmaceutical Market, Global, Late-Stage Pipeline, Merck and Co., 2016 60
Table 13: Membership in PhilHealth, Philippines, Sector Share (%), 2016 78
Table 14: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016 79
Table 15: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015 81
Table 16: Price of Healthcare Products, Philippines Change in Average Price of Health Sector (%), 2008-2014 82
Table 17: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015 118
Table 18: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020 119
Table 19: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015 120
Table 20: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020 121
Table 21: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014 122
Table 22: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013 123
Table 23: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013 124
Table 24: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015 125
Table 25: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014 126
Table 26: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014 127
Table 27: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015 128
Table 28: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015 129
Table 29: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014 130
Table 30: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015 131
Table 31: Economic Indicators, Philippines, External Debt ($bn), 2008-2015 132
Table 32: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2012-2013 134
Table 33: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014 135
Table 34: Demographics, Philippines, Population (million), 2008-2015 136
Table 35: Demographics, Philippines, Population (million), 2016-2020 137
Table 36: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015 138
Table 37: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020 139
Table 38: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015 140
Table 39: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020 141
Table 40: Demographics, Philippines, Births (per 1,000 population), 2008-2014 142
Table 41: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014 143
Table 42: Demographics, Philippines, Major Causes of Mortality (‘000), 2013 144
Table 43: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015 146
Table 44: Demographics, Philippines, Immunization Rate (%), 2008-2014 147
Table 45: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2013 148
Table 46: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2013 149
Table 47: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014 150
Table 48: Demographics, Philippines, Gender Ratio (M/F), 2008-2014 151
Table 49: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015 152
Table 50: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020 153
Table 51: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014 154
Table 52: Demographics, Philippines, Unemployment Rate (%), 2008-2015 155
Table 53: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2013 157
Table 54: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009 159
Table 55: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014 160
Table 56: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014 161
Table 57: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 162
Table 58: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009 163
Table 59: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014 164
Table 60: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014 166
Table 61: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014 167
Table 62: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014 168
Table 63: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014 169
Table 64: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014 170
Table 65: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013 171
Table 66: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014 172
Table 67: Healthcare Market, Philippines, Major Trade Fairs, 2016 174

1.2 List of Figures
Figure 1: Pharmaceutical Market, Philippines, Revenue ($bn), 2008-2015 19
Figure 2: Pharmaceutical Market, Philippines, Revenue Forecast ($bn), 2016-2020 20
Figure 3: Pharmaceutical Market, Philippines, Exports and Imports ($m), 2008-2014 21
Figure 4: Pharmaceutical Distribution Channel, Philippines, Distribution Share (%), 2008 22
Figure 5: Pharmaceutical Market, Philippines, Price Distribution of Pharmaceuticals for Multinational Companies (%), 2008 23
Figure 6: Healthcare Market, Philippines, Drivers and Barriers, 2016 69
Figure 7: Healthcare Market, Philippines, Healthcare System, 2016 70
Figure 8: Healthcare Market, Philippines, Drug Selection Procedure for Philippine National Drug Formulary, 2016 73
Figure 9: Healthcare Market, Philippines, Reimbursement Process, 2016 74
Figure 10: Healthcare Market, Philippines, PhilHealth Milestones, 2016 77
Figure 11: Membership in PhilHealth, Philippines, Sector Share (%), 2016 78
Figure 12: Benefit Payments from PhilHealth, Philippines, Sector Share (%), 2016 79
Figure 13: Healthcare Spending, Philippines, Out-of-Pocket Expenditure (%), 2008-2015 81
Figure 14: Price of Healthcare Products, Philippines, Change in Average Price of Health Sector (%), 2008-2014 82
Figure 15: Healthcare Market, Philippines, Food and Drug Administration Structure, 2014 85
Figure 16: Philippines, Healthcare Market, Approval Process of New Drugs and Medical Devices, 2014 88
Figure 17: Healthcare Market, Philippines, Approval Process of Generic Drugs, 2016 90
Figure 18: Healthcare Market, Philippines, Bureau of Health Devices and Technology Structure, 2016 91
Figure 19: Healthcare Market, Philippines, Licensing Process for Manufacture of Pharmaceuticals and Medical Devices, 2016 92
Figure 20: Healthcare Market, Philippines, Patent Approval Process, 2016 97
Figure 21: Healthcare Market, Philippines, Trademark Approval Process, 2016 98
Figure 22: Healthcare Market, Philippines, Clinical Trial Approval Process, 2014 101
Figure 23: Healthcare Market, Philippines, Procedure for Opening a Retail Pharmacy, 2014 103
Figure 24: Healthcare Policy Initiatives, Philippines, Major Healthcare Reforms, 1999-2014 112
Figure 25: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2008-2015 118
Figure 26: Economic Indicators, Philippines, Gross Domestic Product per Capita ($), 2016-2020 119
Figure 27: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2008-2015 120
Figure 28: Economic Indicators, Philippines, Gross Domestic Product Annual Growth (%), 2016-2020 121
Figure 29: Economic Indicators, Philippines, Gross National Income per Capita ($), 2008-2014 122
Figure 30: Economic Indicators, Philippines, Average Consumer Price Index, 2008-2013 123
Figure 31: Economic Indicators, Philippines, Average Consumer Price Annual Change (%), 2008-2013 124
Figure 32: Economic Indicators, Philippines, Currency Exchange Rate (PHP/$), 2008-2015 125
Figure 33: Economic Indicators, Philippines, Foreign Direct Investment ($bn), 2008-2014 126
Figure 34: Economic Indicators, Philippines, Foreign Exchange Reserves ($bn), 2008-2014 127
Figure 35: Economic Indicators, Philippines, Imports of Goods and Services ($bn), 2008-2015 128
Figure 36: Economic Indicators, Philippines, Exports of Goods and Services ($bn), 2008-2015 129
Figure 37: Economic Indicators, Philippines, Fiscal Deficit (% of GDP), 2008-2014 130
Figure 38: Economic Indicators, Philippines, General Government Gross Debt (% of GDP), 2008-2015 131
Figure 39: Economic Indicators, Philippines, External Debt ($bn), 2008-2015 132
Figure 40: Economic Indicators, Philippines, Major Industries, Industrial Sector, Gross Value Added ($bn), 2013-2014 133
Figure 41: Economic Indicators, Philippines, Major Industries, Service Sector, Gross Value Added ($bn), 2013-2014 134
Figure 42: Demographics, Philippines, Population (million), 2008-2015 136
Figure 43: Demographics, Philippines, Population (million), 2016-2020 137
Figure 44: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2008-2015 138
Figure 45: Demographics, Philippines, Population, Urban and Rural Population Share (%), 2016-2020 139
Figure 46: Demographics, Philippines, Population Distribution by Age Group (%), 2008-2015 140
Figure 47: Demographics, Philippines, Population Distribution by Age Group (%), 2016-2020 141
Figure 48: Demographics, Philippines, Births (per 1,000 population), 2008-2014 142
Figure 49: Demographics, Philippines, Mortality (per 1,000 population), 2008-2014 143
Figure 50: Demographics, Philippines, Major Causes of Mortality (‘000), 2013 144
Figure 51: Demographics, Philippines, Infant Mortality (per 1,000 live births), 2008-2015 145
Figure 52: Demographics, Philippines, Immunization Rate (%), 2008-2014 146
Figure 53: Demographics, Philippines, Major Causes of Male Mortality (‘000), 2013 147
Figure 54: Demographics, Philippines, Major Causes of Female Mortality (‘000), 2013 149
Figure 55: Demographics, Philippines, Maternal Mortality (per 1,000 live births), 2008-2014 150
Figure 56: Demographics, Philippines, Gender Ratio (M/F), 2008-2014 151
Figure 57: Demographics, Philippines, Life Expectancy at Birth (years), 2008-2015 152
Figure 58: Demographics, Philippines, Life Expectancy at Birth (years), 2016-2020 153
Figure 59: Demographics, Philippines, Student Enrollment by Level of Education (%), 2008-2014 154
Figure 60: Demographics, Philippines, Unemployment Rate (%), 2008-2015 155
Figure 61: Demographics, Philippines, Major Diseases, Morbidity (‘000), 2013 156
Figure 62: Demographics, Philippines, Major Diseases, DALYs (per 100,000 population), 2009 158
Figure 63: Healthcare Infrastructure, Philippines, Hospitals, 2008-2014 160
Figure 64: Healthcare Infrastructure, Philippines, Barangay Health Stations, 2008-2014 161
Figure 65: Healthcare Infrastructure, Philippines, Hospitals by Standard of Care, 2009 162
Figure 66: Healthcare Infrastructure, Philippines, Diagnostic Equipment (per 100,000 population), 2007-2009 163
Figure 67: Healthcare Infrastructure, Philippines, Hospitals Beds (per 10,000 population), 2008-2014 164
Figure 68: Environmental Health, Philippines, CO2 Emissions (million metric tons), 2008-2014 166
Figure 69: Environmental Health, Philippines, PM2.5 (µg/m³), 2008-2014 167
Figure 70: Healthcare Personnel, Philippines, Registered Healthcare Personnel, 2008-2014 168
Figure 71: Healthcare Personnel, Philippines, Registered Nurses, 2008-2014 169
Figure 72: Healthcare Expenditure, Philippines, Healthcare Expenditure (% of GDP), 2008-2014 170
Figure 73: Healthcare Expenditure, Philippines, Share of Major Components (%), 2013 171
Figure 74: Healthcare Expenditure, Philippines, Public-Private Share (%), 2008-2014 172
Figure 75: Healthcare Market, Philippines, Opportunities and Challenges, 2016 177

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitor

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Germany Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-El ...

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monit

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

Australia Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro- ...

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical Sensors, Multiparameter Patient Monitorin

  • $ 5995
  • Industry report
  • November 2016
  • by Global Data

India Healthcare IT Market Outlook to 2022 - Clinical IT Systems, Medical Imaging Information Systems, Remote Patient Monitoring, Neonatal Monitors, Fetal Monitors, Blood Pressure Monitors, Micro-Electromechanical ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.